ACR 03-12 is a Phase II clinical trial designed by the American College of Radiology to test the safety and efficacy of 82 GyE (Gray equivalent) delivered using conformal proton beam radiation therapy (PBRT) for the treatment of localized prostate cancer.
Filed under: Management, Treatment | Tagged: high-dose, PBRT, proton beam radiation therapy, toxicity | 2 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site